Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Austra

Hansa Biopharma reports positive efficacy and safety results from Idefirix European post authorizat

Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Prese

U.S. IPO Weekly Recap: Trio Of Sizable Listings Underwhelm To Close Out January

OptiNose (OPTN) came out with a quarterly loss of $1.01 per share versus the Zacks Consensus Estimat

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

OptiNose (OPTN) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimat

The average of price targets set by Wall Street analysts indicates a potential upside of 143.1% in O

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

OptiNose stock surges 53% as it is set to be acquired by Paratek for $330 million, adding chronic rh

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is inves

NEW YORK , March 20, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"),

20 Mar

MONSEY, N.Y., March 20, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigatin

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Optinose (NASDAQ:OPTN) for possible brea

U.S. stock futures rose on Thursday following the Federal Open Market Committee's decision on We

YARDLEY, Pa., March 19, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company fo

Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing th

Preliminary XHANCE prescription growth rate from third quarter to fourth quarter 2024 estimated to b

YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical comp

YARDLEY, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company foc

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earning

U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.

Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second

U.S. stocks traded mostly flat midway through trading, with the S&P 500 turning lower on Wednesd

U.S. stocks traded higher this morning, following the release of economic reports on Wednesday. Fol

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl

  On Monday, 65 companies hit new 52-week lows.

  On Wednesday, 29 companies set new 52-week lows.

  On Tuesday, 69 stocks hit new 52-week lows.

  During Wednesday's session, 212 companies made new 52-week lows.

  On Monday, 85 stocks hit new 52-week lows.

  On Friday, 63 companies hit new 52-week lows.

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings

Companies Reporting Before The Bell • Cohen & Co (AMEX:COHN) is likely to report earnings for i

  Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarte

  Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report

  Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarter

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares surged 55% to close at $1.00 on Tue

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) jumped 65.7% to $1.0691 as the company rep